Analgesics prescribed more heavily to women than to men, study finds

Women suffering from pain tend to be seen only in primary care. Credit: SINC

Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is influenced by socioeconomic inequality between genders in the Autonomous Community in which the patient resides.

In 1999, a researcher at the University of Harvard, Ishiro Kawachi, observed that in the states of the USA with a larger proportion of women with a high social class, mortality in both genders was lower.

Inspired by Kawachi's studies, experts at the University of Alicante have identified how social and between men and women - known as gender-related development - influence the prescription of by area of residence.

"In Spain, as well as in other countries, women suffer from pain more frequently than men, therefore it is logical that they are prescribed more analgesics," Elisa Chilet Rossell, main author of the study recently published in the Gaceta Sanitaria, explains to SINC.

However, this analysis goes one step further and affirms that, regardless of pain, and age, being a woman increases the probability of being prescribed analgesics. "It also depends on whether the patient lives in an Autonomous Community with lower gender development, regardless of whether the patient is male or female," Chilet notes.

For this research, the authors used as their main source of information the 2006 Spanish National Health Survey and the United Nations' Gender-related (GDI), which distinguishes between the development indices of men and women according to life expectancy at birth, education and income.

With this information, they performed a to compare the prescription of analgesics by sex in the areas with higher and lower GDIs than the Spanish national average. The results confirmed a of 29% in the prescription of these medicines.

"The gender bias found could be a way in which inequalities in treatment with analgesics negatively affects women's health," the researcher highlights. "In this way, women receive treatment for symptomatic pain more frequently than men, treatment which can be unspecific and blind to the causes of the pain."

Women are less often seen by specialists

The authors also found that women who suffer and live in a context of lower gender-related development are less likely than men to be seen by specialists and tend to be seen only in primary care.

For these experts, by considering GDI this research contributes a new layer of context to the analysis of inequalities in the prescription of analgesics, and demonstrates that political and economic factors in society influence health problems and their treatment.

"Research on the suitability of analgesics and the medicalisation of women should take account of factors within this environment, as it entails a high cost in terms of 's health and increases pharmaceutical costs, an important consideration in the current climate of economic recession," Chilet concludes.

More information: Chilet-Rosell, E. et al. Inequality in analgesic prescription in Spain. A gender development issue, Gac Sanit. 2013;27(2):135–142

add to favorites email to friend print save as pdf

Related Stories

Men and women get sick in different ways

Mar 22, 2013

At the dawn of third millennium medical researchers still know very little about gender-specific differences in illness, particularly when it comes to disease symptoms, influencing social and psychological factors, and the ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments